D. Bacich

发表

The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.

B. Ristau, D. O’Keefe, D. Bacich, 2014, Urologic oncology.

Induction of autoantibodies to syngeneic prostate‐specific membrane antigen by xenogeneic vaccination

J. Wolchok, H. Scher, A. Houghton, 2005, International journal of cancer.

Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro

D. Bacich, V. Yao, Dean J. Bacich, 2006, The Prostate.

Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic‐derived S‐allylmercaptocysteine

B. Suffoletto, R. Rivlin, D. Bacich, 2000, The Prostate.

In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.

A. Uchida, P. Molloy, D. O’Keefe, 2001, Urology.

Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy.

V. Reuter, N. Bander, P. Gaudin, 2000, Molecular urology.

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.

J. Wolchok, H. Scher, J. Allison, 2004, Vaccine.

A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies

D. O’Keefe, D. Bacich, W. Heston, 2018, The Journal of Nuclear Medicine.

Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N‐acetylaspartylglutamate

J. Neale, T. Bzdȩga, B. Wróblewska, 2002, Journal of neurochemistry.

Prostate-specific membrane antigen is produced in tumor-associated neovasculature.

V. Reuter, P. Gaudin, D. O’Keefe, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Feasibility of dietary folic acid reduction intervention for men on active surveillance for prostate cancer.

J. M. Gutierrez, D. O’Keefe, D. Bacich, 2021, Clinical nutrition ESPEN.

Divergence between dietary folate intake and concentrations in the serum and red blood cells of aging males in the United States.

D. O’Keefe, D. Bacich, Kevin J. Rycyna, 2016, Clinical nutrition.

Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate

R. Dhir, J. Nelson, A. Parwani, 2011, The Prostate.

Contrasting roles of the ABCG2 Q141K variant in prostate cancer

D. O’Keefe, D. Bacich, Jessica L. Cummings, 2017, Experimental cell research.

Characterization and relative abundance of alternatively spliced luteinizing hormone receptor messenger ribonucleic acid in the ovine ovary.

R. Norman, D. Bacich, R. Rodgers, 1994, Endocrinology.

Distribution of the β-core human chorionic gonadotrophin fragment in human body fluids

R. Norman, C. Matthews, D. Bacich, 1992 .

Distribution of the beta-core human chorionic gonadotrophin fragment in human body fluids.

R. Norman, C. Matthews, D. Bacich, 1992, The Journal of endocrinology.

Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.

Lynette M. Smith, P. Rao, D. O’Keefe, 2004, Urologic oncology.

Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study

I. Thompson, J. DiGiovanni, Martin Goros, 2018, Prostate Cancer and Prostatic Diseases.

Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressiveness.

A. Parwani, D. O’Keefe, D. Bacich, 2014, The American journal of pathology.

Characterization of the translated products of the alternatively spliced luteinizing hormone receptor in the ovine ovary throughout the oestrous cycle

R. Norman, D. O’Keefe, D. Bacich, 1999, Molecular and Cellular Endocrinology.

Prostate‐specific suicide gene therapy using the prostate‐specific membrane antigen promoter and enhancer

A. Uchida, F. Watt, P. Molloy, 2000, The Prostate.

Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.

N. Nowak, T. Shows, W. Fair, 1998, Biochimica et biophysica acta.

Comparative analysis of prostate‐specific membrane antigen (PSMA) versus a prostate‐specific membrane antigen‐like gene

D. O’Keefe, D. Bacich, W. Heston, 2004, The Prostate.

Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway

Wasim H. Chowdhury, Zhilong Dong, Zhiping Wang, 2019, International journal of biological sciences.

Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia

D. O’Keefe, D. Bacich, W. Green, 2012, Genes and Immunity.

DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.

R. Dhir, U. Chandran, U. Kelavkar, 2007, Prostaglandins & other lipid mediators.

Rise in serum folate after androgen deprivation associated with worse prostate cancer-specific survival.

D. Bacich, M. Liss, Arpan Satsangi, 2020, Urologic oncology.

mTOR inhibitors for treatment of low-risk prostate cancer.

I. Thompson, Z. D. Sharp, L. Degraffenried, 2018, Medical hypotheses.

False negative results from using common PCR reagents

D. O’Keefe, D. Bacich, Denise S O'Keefe, 2011, BMC Research Notes.

Opposing roles of folate in prostate cancer.

D. O’Keefe, D. Bacich, Kevin J. Rycyna, 2013, Urology.

NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test.

J. Neale, T. Bzdȩga, D. Bacich, 2013, European journal of pharmacology.

Expression of prostate‐specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non‐polyglutamated folate, folic acid

D. O’Keefe, D. Bacich, V. Yao, 2010, The Prostate.

Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.

A. Parwani, D. Bacich, W. Heston, 2008, Cancer research.

Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase

W. Tong, D. Bacich, W. Heston, 2001, Mammalian Genome.

D. O’Keefe, D. Bacich, V. Yao, 2010, The Prostate.

Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study

I. Thompson, J. DiGiovanni, Martin Goros, 2018, Prostate Cancer and Prostatic Diseases.

Deficiency of DNA repair nuclease ERCC1‐XPF promotes prostate cancer progression in a tissue recombination model

A. Parwani, Jennifer L. Gregg, L. Niedernhofer, 2012, The Prostate.

A Perspective on the Evolving story of PSMA Biology and PSMA Based Imaging and Endoradiotherapeutic Strategies.

D. O’Keefe, D. Bacich, Warren D. W. Heston, 2018 .

MP66-19 PROSTATE-SPECIFIC MEMBRANE ANTIGEN INTERACTS WITH DIETARY FOLATE TO FACILITATE PROSTATE CARCINOGENESIS AND PROGRESSION

Jennifer L. Gregg, B. Ristau, D. O’Keefe, 2016 .

Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.

A. Parwani, D. Bacich, W. Heston, 2008, Cancer Research.

Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury

N. Callizot, D. Bacich, W. Heston, 2005, Journal of neurochemistry.

Nuclear NADPH Oxidase-4 Associated With Disease Progression In Renal Cell Carcinoma.

K. Block, D. O’Keefe, D. Bacich, 2020, Translational research : the journal of laboratory and clinical medicine.